Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron dosing regimens plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in children
ChiCTR-IPR-16008981Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of palonosetron and dexamethasone in chemotherapy-induced nausea and vomiting (CINV) (4 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: Incidence of nausea, Incidence of vomiting and 1 more. Started Aug 2016; status: recruiting.
02
Drugs
palonosetrondexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR-IPR-16008981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008981.